Literature DB >> 19895988

Epicutaneous allergen administration: a novel approach for allergen-specific immunotherapy?

Thomas Werfel.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19895988     DOI： 10.1016/j.jaci.2009.09.049

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  8 in total

Review 1.  Genetics of Food Allergy.

Authors:  Elisabet Johansson; Tesfaye B Mersha
Journal:  Immunol Allergy Clin North Am       Date:  2021-03-26       Impact factor: 3.479

2.  Therapeutic potential of semi-mature dendritic cells for tolerance induction.

Authors:  Manfred B Lutz
Journal:  Front Immunol       Date:  2012-05-18       Impact factor: 7.561

3.  Transcutaneous delivery of CpG-adjuvanted allergen via laser-generated micropores.

Authors:  Michael Hessenberger; Richard Weiss; Esther E Weinberger; Christof Boehler; Josef Thalhamer; Sandra Scheiblhofer
Journal:  Vaccine       Date:  2012-12-27       Impact factor: 3.641

Review 4.  Allergen immunotherapy: routes, safety, efficacy, and mode of action.

Authors:  Jillian Leigh Hochfelder; Punita Ponda
Journal:  Immunotargets Ther       Date:  2013-07-22

5.  Transcutaneous immunotherapy via laser-generated micropores efficiently alleviates allergic asthma in Phl p 5-sensitized mice.

Authors:  D Bach; R Weiss; M Hessenberger; S Kitzmueller; E E Weinberger; W D Krautgartner; C Hauser-Kronberger; C Boehler; J Thalhamer; S Scheiblhofer
Journal:  Allergy       Date:  2012-09-05       Impact factor: 13.146

6.  Epicutaneous Immunotherapy Compared with Sublingual Immunotherapy in Mice Sensitized to Pollen (Phleum pratense).

Authors:  Lucie Mondoulet; Vincent Dioszeghy; Mélanie Ligouis; Véronique Dhelft; Emilie Puteaux; Christophe Dupont; Pierre-Henri Benhamou
Journal:  ISRN Allergy       Date:  2012-02-02

7.  Transcutaneous Delivery of Immunomodulating Pollen Extract-Galactomannan Conjugate by Solid-in-Oil Nanodispersions for Pollinosis Immunotherapy.

Authors:  Qingliang Kong; Kouki Higasijima; Rie Wakabayashi; Yoshiro Tahara; Momoko Kitaoka; Hiroki Obayashi; Yanting Hou; Noriho Kamiya; Masahiro Goto
Journal:  Pharmaceutics       Date:  2019-10-30       Impact factor: 6.321

8.  Heat-labile Escherichia coli toxin enhances the induction of allergen-specific IgG antibodies in epicutaneous patch vaccination.

Authors:  C R Cabauatan; R Campana; K Niespodziana; C Reinisch; U Lundberg; A Meinke; R Henning; A Neubauer; R Valenta
Journal:  Allergy       Date:  2016-09-30       Impact factor: 13.146
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.